Minaris Advanced Therapies Welcomes New CEO Dr. Orla Cloak

• Minaris Advanced Therapies has appointed Dr. Orla Cloak as Chief Executive Officer.

• Dr. Cloak brings over 20 years of commercial leadership experience in the Pharma and Life Science sectors.

Minaris Advanced Therapies has appointed Dr. Orla Cloak as its new Chief Executive Officer. The announcement marks a leadership transition aimed at supporting the company’s continued growth and strategic direction in the advanced therapies space.

Dr. Cloak joins the company with more than two decades of experience in commercial leadership across the Pharma and Life Science industries. Prior to this role, she held senior leadership positions at Lonza, including Senior Vice President and Head of the Lonza Bioscience business, over a 17-year tenure.

Iain Baird, Chairman of the Board at Minaris Advanced Therapies, welcomed the appointment, stating, “On behalf of the board, I am delighted to welcome Orla to Minaris Advanced Therapies. Her leadership will be instrumental to achieving our mission of supporting customers to successfully commercialize their innovative therapies.”

Dr. Cloak holds a Bachelor of Science degree from University College Dublin and a Doctorate in Microbiology from the University of Ulster. Reflecting on her new role, she said, “I am honored to join Minaris Advanced Therapies at such a pivotal time. I look forward to working with the talented team here to build on the company’s strong foundations and drive its next phase of growth.”